Craig Stuart Pace

Title: Craig Stuart Pace: Innovator in HIV Antibody Research

Introduction

Craig Stuart Pace is a notable inventor based in Pacifica, CA (US). He has made significant contributions to the field of HIV research, particularly in the development of innovative antibody therapies. With a total of 2 patents, his work focuses on enhancing the efficacy of treatments for HIV.

Latest Patents

One of Craig's latest patents is titled "Engineering pH-dependent antigen binding activity into anti-HIV antibodies with improved pharmacokinetics." This patent discloses a histidine-mutated anti-HIV antibody that includes specific mutations in the heavy and light chains of ibalizumab. These mutations aim to improve the antibody's binding activity and pharmacokinetics. Another significant patent is "Fusion antibodies for HIV therapy," which describes fusion antibodies designed to target both the CD4 receptor and the HIV envelope. These fusion antibodies demonstrate improved potency and breadth against HIV compared to traditional monospecific antibodies, providing a high barrier against viral resistance.

Career Highlights

Craig Stuart Pace is affiliated with The Rockefeller University, where he continues to advance research in antibody therapies. His innovative approaches have the potential to transform HIV treatment and improve patient outcomes.

Collaborations

Craig collaborates with esteemed colleagues, including David Joon Ho and Yaoxing Huang, to further enhance the impact of his research.

Conclusion

Craig Stuart Pace is a pioneering inventor whose work in HIV antibody research is paving the way for more effective therapies. His contributions are vital in the ongoing fight against HIV, showcasing the importance of innovation in medical science.